| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.008 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |